# Evaluation of the Effect of Artesunate in Friedreich Ataxia (FA)

> **NCT04921930** · PHASE1,PHASE2 · COMPLETED · sponsor: **Institut National de la Santé Et de la Recherche Médicale, France** · enrollment: 20 (actual)

## Conditions studied

- Friedreich Ataxia

## Interventions

- **DRUG:** Artesunate Oral Product

## Key facts

- **NCT ID:** NCT04921930
- **Lead sponsor:** Institut National de la Santé Et de la Recherche Médicale, France
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-06
- **Primary completion:** 2024-04-17
- **Final completion:** 2024-04-17
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04921930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04921930, "Evaluation of the Effect of Artesunate in Friedreich Ataxia (FA)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04921930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*